Stock Analysis

Undiscovered Gems In The United States To Explore December 2024

Published

Over the last 7 days, the United States market has experienced a 3.5% drop, yet it has risen by 22% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can provide valuable opportunities for investors seeking undiscovered gems.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Eagle Financial Services170.75%12.30%1.92%★★★★★★
Wilson Bank HoldingNA7.87%8.22%★★★★★★
Franklin Financial Services173.21%5.55%-1.86%★★★★★★
Omega FlexNA0.39%2.57%★★★★★★
Parker Drilling46.05%0.86%52.25%★★★★★★
First Northern Community BancorpNA7.65%11.17%★★★★★★
TeekayNA-3.71%60.91%★★★★★★
ASA Gold and Precious MetalsNA7.11%-35.88%★★★★★☆
Pure Cycle5.31%-4.44%-5.74%★★★★★☆
FRMO0.13%19.43%29.70%★★★★☆☆

Click here to see the full list of 240 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

We're going to check out a few of the best picks from our screener tool.

Aehr Test Systems (NasdaqCM:AEHR)

Simply Wall St Value Rating: ★★★★★★

Overview: Aehr Test Systems, Inc. offers semiconductor test solutions globally, focusing on wafer level and package part forms, with a market cap of $404.76 million.

Operations: Aehr Test Systems generates revenue primarily from designing, manufacturing, and marketing advanced test and burn-in products, amounting to $58.71 million. The company has a market cap of $404.76 million.

Aehr Test Systems, a nimble player in the semiconductor space, has shown impressive earnings growth of 56.7% over the past year, outpacing the industry average of -3.6%. Despite this growth, its recent share price volatility and shareholder dilution raise some concerns. The company is debt-free now compared to a 17.4% debt-to-equity ratio five years ago and has a favorable price-to-earnings ratio of 13.5x against the broader US market's 18.2x. Recent milestones include securing AI customer orders valued at over $10 million, though legal challenges may impact investor sentiment moving forward.

NasdaqCM:AEHR Debt to Equity as at Dec 2024

SIGA Technologies (NasdaqGM:SIGA)

Simply Wall St Value Rating: ★★★★★★

Overview: SIGA Technologies, Inc. is a commercial-stage pharmaceutical company specializing in health security markets within the United States, with a market cap of $409.15 million.

Operations: SIGA Technologies generates revenue primarily from its pharmaceuticals segment, which reported $173.73 million.

SIGA Technologies, a nimble player in the pharmaceuticals sector, has made significant strides by becoming profitable recently. Trading at 81.9% below its estimated fair value, this debt-free company shows promise with high-quality non-cash earnings and positive free cash flow. In recent developments, SIGA amended its bylaws to align with SEC's universal proxy rules and expanded procedural requirements for shareholder proposals. However, tecovirimat’s efficacy in treating mpox was questioned following an NIH trial recommendation to halt patient enrollment due to lack of demonstrated benefit compared to placebo, though safety profiles remain robust across studies.

NasdaqGM:SIGA Earnings and Revenue Growth as at Dec 2024

Exodus Movement (NYSEAM:EXOD)

Simply Wall St Value Rating: ★★★★★★

Overview: Exodus Movement, Inc. operates as a financial technology company within the blockchain and digital asset industry in the United States, with a market cap of approximately $1.48 billion.

Operations: Exodus Movement generates revenue primarily from data processing, amounting to $89.94 million. The company's financial performance is characterized by its focus on this core revenue stream within the blockchain and digital asset sector.

Exodus Movement, a nimble player in the software space, has showcased significant growth recently. With sales jumping to US$20.12 million in Q3 2024 from US$11.98 million a year ago and net income reaching US$0.843 million compared to a previous loss, it seems the company is on an upward trajectory. Despite being debt-free and boasting a favorable price-to-earnings ratio of 25.2x against the industry average of 40.8x, its share price remains volatile over recent months. While free cash flow isn't positive, Exodus's profitability and high non-cash earnings indicate potential resilience amidst market fluctuations.

NYSEAM:EXOD Debt to Equity as at Dec 2024

Taking Advantage

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com